Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9241 |
High Similarity |
NPD6190 |
Approved |
0.8718 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8457 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8457 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8457 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8434 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8424 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8418 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8367 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8365 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8354 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8291 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8284 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8242 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8219 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8193 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8176 |
Intermediate Similarity |
NPD37 |
Approved |
0.8153 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8137 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8137 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8137 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8125 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.811 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8095 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8089 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8086 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8084 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8075 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8047 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8047 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8036 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8036 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8025 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8024 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8013 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7964 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7952 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7939 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7937 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7901 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7898 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7867 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7815 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7815 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7811 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7808 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7718 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7679 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD5494 |
Approved |
0.764 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7625 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7619 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7607 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7576 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7566 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7561 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7558 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7529 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7528 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7455 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7455 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7453 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7429 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7416 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD919 |
Approved |
0.7386 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7375 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7375 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7355 |
Intermediate Similarity |
NPD943 |
Approved |
0.7347 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7342 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7308 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7301 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD2533 |
Approved |
0.729 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7283 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7255 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7234 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7232 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7226 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7209 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7204 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7166 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6781 |
Approved |
0.716 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7126 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7097 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7091 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7091 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7089 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7086 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7063 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7059 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7059 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7034 |
Intermediate Similarity |
NPD228 |
Approved |
0.7024 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7013 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7012 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7012 |
Intermediate Similarity |
NPD3887 |
Approved |
0.701 |
Intermediate Similarity |
NPD7874 |
Approved |
0.701 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.6983 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6974 |
Remote Similarity |
NPD1535 |
Discovery |
0.6963 |
Remote Similarity |
NPD7697 |
Approved |
0.6963 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6963 |
Remote Similarity |
NPD7698 |
Approved |
0.6961 |
Remote Similarity |
NPD8312 |
Approved |
0.6961 |
Remote Similarity |
NPD8313 |
Approved |
0.6959 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6954 |
Remote Similarity |
NPD17 |
Approved |
0.6946 |
Remote Similarity |
NPD6273 |
Approved |
0.6937 |
Remote Similarity |
NPD6653 |
Approved |
0.6933 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6933 |
Remote Similarity |
NPD4534 |
Discontinued |
0.6928 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6923 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD3620 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD2438 |
Suspended |
0.6907 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD920 |
Approved |
0.6903 |
Remote Similarity |
NPD1203 |
Approved |
0.6898 |
Remote Similarity |
NPD6535 |
Approved |
0.6898 |
Remote Similarity |
NPD6534 |
Approved |
0.6879 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD1358 |
Approved |
0.6875
|
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |